In the long history of healing, human hands have always borne the burden of care — sometimes at great cost to themselves. At a Beijing hospital, a new chapter is quietly being written: robotic arms now perform the repetitive, hazardous work of preparing intravenous medications, sparing pharmacists from occupational injury while leaving the deeper judgments of medicine firmly in human hands. This is not a story of replacement, but of a thoughtful redistribution of labor — technology absorbing what exhausts and endangers, so that expertise may be directed toward what truly requires it.
Chinese hospitals deploy robotic pharmacists to automate drug preparation, reduce injury risk
Eliminates workplace injuries including tendonitis, wrist strain, and hazardous chemical exposure affecting healthcare workers preparing intravenous medications.
A good tool doesn't just follow orders. It brings out the best in the person using it.
Mark
Why does this matter now, when pharmacists have been doing this work for decades?
Mimi
Because the cost has always been paid in the bodies of the people doing it. Tendonitis, wrist strain, exposure to hazardous drugs—these aren't minor inconveniences. They're occupational injuries that accumulate over years. The robot doesn't eliminate the work; it eliminates the injury.
Mark
But doesn't automation always threaten jobs?
Mimi
Not this one. The system cuts staffing needs by 80 percent, yes, but it doesn't eliminate the pharmacist. It eliminates the repetitive, physically draining part of the work. The pharmacist still makes all the complex decisions—drug compatibility, unusual doses, anything that requires judgment.
Mark
So the pharmacist becomes more of a supervisor?
Mimi
More than that. They become a decision-maker. Right now, Chen spends her shift on mechanical tasks. With the robot, she can focus on what only a human can do—think critically about each prescription, catch potential problems, communicate with patients and doctors.
Mark
What's the next step Fu is planning?
Mimi
He wants to give the robot a brain—artificial intelligence that learns from every dose it prepares. Imagine a system that recognizes patterns across thousands of past prescriptions and can flag a potential drug interaction before it happens. The pharmacist still approves everything, but now they have an intelligent assistant.
Mark
Is this technology spreading beyond China?
Mimi
Already. Thailand's largest public hospital has agreed to collaborate. Representatives from Singapore, Malaysia, Japan, Italy, and the United States have come to study it. Fu is working on certification for different countries' regulatory systems. The underlying problem—keeping people safe while protecting workers—is universal.
Mark
What does Fu think this technology is really for?
Mimi
He said it best: "Not every breakthrough needs to be a rocket launch. Some of the most important ones simply make a patient's infusion a little safer, and a pharmacist's work a little lighter."
Le Pouls
- Years of manual IV drug preparation have left pharmacists across China with tendonitis, wrist damage, and chronic exposure to hazardous chemotherapy compounds — a quiet occupational crisis hiding in plain sight.
- A fully automated robotic system deployed at Beijing's Tongzhou Anzhen Hospital now handles the entire standardized admixture process, cutting staffing needs by over 80% and operating three to five times faster than human teams.
- Pharmacists like Chen Tingyu have not been sidelined — they oversee the system, manage complex formulations, and retain authority over every judgment that falls outside the machine's standardized scope.
- An AI-powered upgrade planned for year-end would allow the system to learn from thousands of past prescriptions, flag potential issues, and offer clinical suggestions — all subject to mandatory pharmacist review before any compounding begins.
- International momentum is building rapidly, with Thailand's largest public hospital set to formalize a partnership in September and delegations from Singapore, Japan, Italy, and the United States already studying the technology on the ground.
In the long history of healing, human hands have always borne the burden of care — sometimes at great cost to themselves. At a Beijing hospital, a new chapter is quietly being written: robotic arms now perform the repetitive, hazardous work of preparing intravenous medications, sparing pharmacists from occupational injury while leaving the deeper judgments of medicine firmly in human hands. This is not a story of replacement, but of a thoughtful redistribution of labor — technology absorbing what exhausts and endangers, so that expertise may be directed toward what truly requires it.
There is an old childhood fear attached to hospitals — the held breath as a nurse snaps open a glass vial, the worry of a shard finding its way somewhere it shouldn't. That fear is being retired at Beijing's Tongzhou Anzhen Hospital, where three robotic arms now work in synchronized precision to prepare intravenous medications that were once mixed entirely by hand.
Pharmacist Chen Tingyu calls the machine her "hand-saving partner." Her role has shifted: she loads medications, logs them into the system, and taps a screen when a prescription arrives. The robot handles the rest — one arm gripping the IV bag, another the vial, a third the syringe. What she no longer does is the grinding repetitive labor that, over years, leaves pharmacists with tendonitis, wrist strain, and in some cases chronic exposure to hazardous chemotherapy compounds.
The system was developed by Fu Xiaoyang, a pharmacy-trained founder who once prepared IV drugs himself and recognized the work's industrial character. His team spent four years building the fully automated platform and two more testing it in hospitals before commercial trials began last year. The results are striking: the system compresses what once required hundreds of square meters into a footprint of eight, and operates three to five times faster than manual methods.
But the technology is deliberately bounded. Complex formulations, unusual dosages, and drug compatibility judgments remain the pharmacist's domain. Liu Zhongjun of Peking University Third Hospital articulates the underlying philosophy: technology in healthcare should free professionals from repetitive burden, not displace their expertise.
Fu's next step is to give the system a "brain" — AI capable of learning from every dose prepared, recognizing patterns across prescriptions, and surfacing clinical suggestions for pharmacist review. Any compounding plan the system generates would still require human approval before proceeding. He also envisions compact versions deployed in community clinics and even emergency rescue vehicles, extending the technology's reach to settings where experienced pharmacists are scarce.
Policy tailwinds are accelerating the vision. China's National Health Commission issued guidelines last November calling for deep AI integration across the health sector. Siriraj Hospital in Thailand — the country's largest public hospital — has confirmed plans to collaborate, with a formal agreement expected in September. Delegations from Singapore, Malaysia, Japan, Italy, and the United States have already traveled to study the equipment. "Healthcare systems differ from country to country," Fu said, "but the desire to keep people safe and well is the same everywhere."
There is a particular anxiety that belongs to childhood: watching a nurse crack open a glass vial, holding your breath against the possibility of a shard finding its way into your bloodstream. That old fear is being retired now, not by caution or better technique, but by three robotic arms working in synchronized precision at a Beijing hospital.
At Tongzhou branch of Beijing Anzhen Hospital, pharmacist Chen Tingyu oversees a machine that has become, in her words, her "hand-saving partner." The system works with elegant division of labor: one arm grips the intravenous infusion bag, another handles the vial, a third operates the syringe. Chen no longer does this work herself. She loads drawers with medications, logs their names and quantities into the system, and when a prescription arrives, she taps the screen. The robot takes it from there.
Before this machine arrived, Chen's shifts were consumed by repetitive manual labor—vial after vial snapped open, dose after dose drawn, drug after drug mixed by hand. The physical cost accumulates. Pharmacists who spend years in this work develop occupational injuries: tendonitis, wrist strain, the slow degradation of hands and forearms. When hazardous medicines are involved—chemotherapy drugs, for instance—the exposure risk compounds. The U.S. National Institute for Occupational Safety and Health has documented both acute and chronic health effects in workers who prepare or administer such compounds.
Fu Xiaoyang, founder of Meilan PIVAS Robots Co., Ltd, understands this intimately. He trained in pharmacy at one of China's top medical schools and once prepared intravenous drugs himself. When he turned his attention to industrial robotics for healthcare, he knew exactly where his expertise could matter most. "Pharmacy intravenous admixture closely resembles an industrial production line," he observed. "It is a perfect setting for robots to take the lead, not just assist." His team spent four years developing the fully automated system, then two more years testing it in hospitals. Commercial trials began only last year.
The numbers are striking. The system replaces an entire pharmacy intravenous admixture center—typically spanning hundreds of square meters—with a footprint of just eight. It cuts staffing needs by over 80 percent and operates three to five times faster than traditional manual methods. The robot never tires, never deviates from standardized procedures. Chen says she feels more confident in every infusion bag that leaves the room now. But she does not see the machine as a replacement. Complex formulations, unusual doses, judgments about drug compatibility—these still require a pharmacist's expertise and judgment. The robot handles only what is repetitive and physically draining.
Liu Zhongjun, director of the spinal surgery institute at Peking University Third Hospital, frames this philosophy clearly: the goal of technology in healthcare is not to replace medical professionals, but to free them from repetitive tasks and create space for communication and patient care. Fu's vision extends further. The current system relies on programmed procedures, but he is working toward giving the robotic arms what he calls a "brain"—the ability to recognize variations in drug containers, coordinate more flexibly, monitor wear-prone components, and alert staff to maintenance needs. He imagines a future where a pharmacist could simply ask the system to prioritize an urgent prescription instead of manually rearranging the sequence.
The next major upgrade, planned for completion by year's end, aims to integrate artificial intelligence that learns from every dose prepared. Drawing on a growing library of past prescriptions, such a system could recognize patterns across cases and offer clinical suggestions displayed on screen for the pharmacist to review. When it detects a potential issue, it flags an alert. But Fu is clear: any handling plan generated by the system would still require pharmacist review and approval before compounding begins. Professional judgment remains firmly in human hands.
Fu has long advocated for bringing this technology to community-level healthcare facilities, where experienced pharmacists are scarce. An AI-powered assistant drawing on thousands of prior cases could offer clinical suggestions that would be invaluable on the front lines. The system is compact enough even to be loaded onto emergency rescue vehicles for disaster relief. Policy support is accelerating this vision. Last November, China's National Health Commission, together with four other government departments, issued a guideline calling for AI to be deeply integrated into the health sector. That momentum is already translating into concrete partnerships. Siriraj Hospital, Thailand's largest public hospital, has confirmed its intent to collaborate, with a formal agreement expected in September. Hospital and industry representatives from Singapore, Malaysia, Japan, Italy, and the United States have traveled to China to study the equipment. Fu is working on certification and adapting the system to different countries' regulatory requirements and pharmaceutical workflows. "Healthcare systems differ from country to country," he said, "but the desire to keep people safe and well is the same everywhere."
Citations marquantes
Pharmacists who do this for years often develop occupational injuries, such as tendonitis and wrist strain.— Chen Tingyu, pharmacist at Beijing Anzhen Hospital
The goal of technology advance in healthcare is not to replace medical professionals, but to relieve them of repetitive tasks and allow more time for communication and patient care.— Liu Zhongjun, director of spinal surgery institute at Peking University Third Hospital
Envie de l'histoire complète ?
Lire l'original sur CCTV.com English ↗
Health & Medicine